MedTrace Logo

Prometra's Utilization in Mitigating Pain (PUMP)

NCT00817596 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2012-08-17

Study results available
· View outcomes & findings →

Summary

Clinical evaluation of the safety and efficacy of the Prometra Programmable Infusion Pump to accurately supply drug to the intrathecal space for the treatment of chronic pain.

Conditions

  • Intractable Pain

Interventions

DEVICE

Infusion Pump (Prometra)

Implantation of pump/catheter for infusion of morphine into the intrathecal space

Sponsors & Collaborators

  • Flowonix Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00817596 on ClinicalTrials.gov